Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30 USD | +1.01% | +4.16% | -28.65% |
04-20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
04-20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.65% | 4.32B | |
+20.29% | 47.02B | |
+49.28% | 41.86B | |
+0.16% | 41.76B | |
-4.27% | 28.8B | |
+11.82% | 26.05B | |
-22.03% | 19.15B | |
+4.42% | 12.55B | |
+28.84% | 12.34B | |
-4.79% | 11.82B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- UBS Raises Immunovant Price Target to $56 From $55, Maintains Buy Rating